NCT05737355View on ClinicalTrials.gov

Effect of ANKASCIN 568-P Products Regulating Blood Lipid

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Hyperlipidemias
Interventions
DIETARY_SUPPLEMENT

ANKASCIN 568-P Red yeast rice capsules

Product ingredients: ANKASCIN 568-P red yeast rice product 440 mg,microcrystalline ,cellulose,Maltodextrin; capsule shell composition: HPMC (hydroxypropyl methylcellulose), purified water, titanium dioxide, gellan gum.

DIETARY_SUPPLEMENT

Placebo Capsules

Maltodextrin was used as a placebo

Trial Locations (1)

114202

RECRUITING

Tri-Service General Hospital, National Defense Medical Center, Taipei city,, Taipei

All Listed Sponsors
lead

SunWay Biotech Co., LTD.

INDUSTRY